Mutational Analysis as a Prognostic and Predictive Marker of Cardiovascular (CVD) Disease in Patients With Myelodysplasia
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to MDS
Related studies linked through entity extraction aliases.
CPX-351 in Patients Treated for Higher-risk Myelodysplastic Syndromes Experiencing Hypomethylating Agent Failure.
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Oligoblastic AML
- Status
- RECRUITING
- Phase
- PHASE2
CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory AML or MDS
- Status
- COMPLETED
- Phase
- PHASE1
Study on High-risk MDS Patients Based on RNA-seq Technology
- Status
- UNKNOWN
- Phase
- N/A
Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS
- Status
- UNKNOWN
- Phase
- PHASE1
APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE3
Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies
- Status
- RECRUITING
- Phase
- N/A
Study of APVO436 in Patients With AML or MDS
- Status
- UNKNOWN
- Phase
- PHASE1
Ascorbic Acid Levels in MDS, AML, and CMML Patients
- Status
- COMPLETED
- Phase
- N/A
DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Pevonedistat and Low Dose Cytarabine in Adult Patients With AML and MDS
- Status
- COMPLETED
- Phase
- PHASE1
Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCT
- Status
- UNKNOWN
- Phase
- PHASE2
Haploidentical Donor vs mMUD in Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
iCare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AML
- Status
- WITHDRAWN
- Phase
- N/A
Familial Investigations of Childhood Cancer Predisposition
- Status
- RECRUITING
- Phase
- N/A
CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Azacitidine in Myelodysplastic Syndrome (MDS) Associated to Systemic Auto-immune and Inflammatory Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Individual Molecular MRD Monitoring for MDS Patients After Allo-SCT
- Status
- COMPLETED
- Phase
- N/A